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Abstract
Background
HPV infection causes cervical cancer, a major contributor to morbidity and mortality among
low-income Mexican women. Human papillomavirus (HPV) DNA testing is now a primary
screening strategy in Mexico’s early cervical cancer detection program (ECDP). Research
on Mexican women’s perceptions of HPV and testing is necessary for establishing culturally
appropriate protocols and educational materials. Here, we explore perceptions about HPV
and HPV-related risk factors among low-income Mexican ECDP participants.
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Methods
We conducted semi-structured interviews with 24 ECDP participants from two primary care
health clinics in Michoacán state, Mexico. Interviews addressed women’s understandings
of and experiences with HPV and HPV testing. Analysis was inductive and guided by the
Health Belief Model with a focus on gender.

Results
Women’s confusion about HPV and HPV screening caused emotional distress. They understood HPV to be a serious disease that would always cause severe symptoms, often characterizing it as analogous to HIV or inevitably carcinogenic. Women also attributed it to
men’s sexual behaviors, specifically infidelity and poor hygiene. Women described both
sexes’ desire for sex as natural but understood men’s negative practices of masculinity, like
infidelity, as the causes of women’s HPV infection. Some women believed dirty public bathrooms or heredity could also cause HPV transmission.
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Conclusions
These results are consistent with prior findings that geographically and economically
diverse populations lack clear understandings of the nature, causes, or symptoms of HPV,
even among those receiving HPV testing. Our findings also reveal that local cultural discourse relating to masculinity, along with failure to provide sufficient education to lowincome and indigenous-language speaking patients, exacerbate women’s negative emotions surrounding HPV testing. While negative emotions did not deter women from seeking
testing, they could be ameliorated with better health education and communication.

Introduction
Cervical cancer is one of the main causes of morbidity and mortality among Mexican women, especially low-income women, despite the presence of a national early cervical cancer detection program (ECDP) since the 1970s. [1–4] In 2008, this program switched from cytology to HPV testing
as the primary cervical cancer screening tool.[5,6] This screening strategy is promising since HPV
testing is more sensitive than cervical cytology for detecting high-degree lesions, is more cost-effective than cytology, and is more feasible than cytology in developing countries that face economic
and organizational barriers to comprehensive cytology-based screening programs.[1,7–14]
Despite the benefits that HPV testing offers as a primary ECDP screening tool, the concept
of cervical cancer and screening as virus-related have been found to cause some negative psychosocial effects. Women being tested for or diagnosed with HPV may experience anguish,
anxiety, confusion, fear or stigma.[15–19] These experiences might deter women from undergoing HPV testing and cervical cancer screening.[20,21]
Such perceptions and experiences regarding HPV and other sexually-transmitted infections
(STIs) are profoundly shaped by local culture, especially norms and beliefs regarding sexuality
and gender.[17,22] In Mexico, STIs are often stigmatized, posing a risk of emotional suffering
that might outweigh their biological risk.[23] Popular cultural understandings of STIs are also
powerfully linked to gender norms, including nationwide critique of “macho” masculinities
characterized by infidelity,[24,25] and local patterns of male work migration such as the largescale male migration that occurs in Michoacán.[26]
For these reasons, it is important to assess women’s beliefs about and experiences of HPV in
diverse local contexts, in order to understand how they might influence women’s screening
experiences. This information is also important for developing educational materials and culturally-sensitive screening protocols, which would increase ECDP use and mitigate any psychosocial harm that screening might pose. Here, we focus on the ECDP experiences of lowincome Mexican women in marginalized areas of Michoacán state.

Methods
Ethics statement and informed consent procedure
All participants provided verbal informed consent, which we employed since low levels of education and literacy in the study population made written consent inappropriate. Consent was
obtained through the following procedure. The principal investigator read the letter of
informed consent to each potential participant, which included a description of the study
including its objectives, potential risks and benefits, the voluntary nature of participation and
participants’ ability to withdraw at any time. Potential participants were also given an information card that listed the study title, names, titles and contact information for the ethics board
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members and study principal investigator, and a statement that the participant could call and
ask for information or make comments or complaints. The principal investigator also read
this card aloud to potential participants. Women who wished to participate then gave verbal
consent, which was audio recorded. As mandated by the local ethics board, this procedure
occurred in the presence of at least one witness. This study, including the verbal consent procedure and script followed, was approved by the Mexican National Institute of Public Health Ethics Board (IRB).

Study Setting and Participants
We conducted semi-structured interviews with women who underwent HPV testing in the
ECDP in order to explore their beliefs and perceptions regarding HPV. Participants were
ECDP service users drawn from the patient pools of two primary health care centers in the
Michoacán State Health Service. These two health centers were selected because they were
located in low-income municipalities but served populations that varied ethnically. One center
was in the state capital of Morelia, and had a Spanish-speaking, mestizo population. The other
center was in the town of Chilchota in Northern Michoacán, which had a large indigenous
population composed of Purepecha and Tarasco speakers who had experienced a long history
of marginalization from state and economic offerings.[27] We drew participants from both
locations in order to assess whether marginalization based on indigenous status influenced
women’s perceptions of HPV in Michoacán state. [28]

Procedures
From each municipal health care center, we received a list of women who had undergone HPV
testing and were given results within the past month. We then verbally invited those women to
participate, stopping after 12 women from each site had agreed to participate. Invitations were
given in one of three ways: in person at a woman’s next clinical appointment if she had one
scheduled during the recruitment period, over the telephone, or at her home if she could not be
reached by phone and did not have an appointment scheduled. We explained the purpose of
the study, the fact that her participation was voluntary, and that her information would be confidential. We also described the study aims and methods. We then explained the study and collected verbal informed consent from women who wished to participate, as discussed above.
Interviews with consenting participants subsequently took place in private rooms at the clinical
sites, with the exception of three which were held in private spaces in the homes of Morelia participants for their convenience.
The design of the broader study of women’s and healthcare providers’ HPV-related experiences, of which this research forms a part, is described in detail elsewhere.[29] Participants in
the present analysis responded to an interview guide administered in Spanish by a Mexican
female investigator trained in qualitative research methods (Table 1). In the semi-structured
interview format, open-ended questions served as starting points from which participants
could add additional information and introduce new themes.
Questions collected sociodemographic data and assessed participants’ perceptions and phenomenological experiences of HPV and HPV testing. Question design was guided by the Health Beliefs
Model (HBM), which indicates that experiences of vulnerability (in this case, perceptions of the
physical and social risks of HPV) and perceptions of severity or seriousness of an event (here, the
perceived implications of HPV infection) together influence adoption of preventative behavior (in
this case, undergoing screening).[30] Interviews lasted half an hour on average, and were audio
recorded with last names excluded. Recordings were subsequently transcribed by trained transcriptionists, and the authors translated the quotations presented here into English.
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Table 1. Semi-structured interview questions.
HPV testing motivations
Why did you decide to get the HPV test?
Why did you think it was necessary to do it?
Would you recommend the HPV test to a friend, relative or neighbor? Why?
In your view, why do women need to get the HPV test?
How would you convince someone to get the HPV test? What would you say to motivate her?
Does a woman’s partner inﬂuence her decision to get these tests? How and why?
Why do you think that women don’t get the HPV test?
Experience of receiving HPV test results
How was getting the results? What did they (health professionals) tell you?
Did they explain the results in a way that was easy to understand?
What else would you have liked them to explain?
Could you ask questions? Did you ask any questions?
Do you still have questions?
Can you think of anything you would have liked to ask?
How did you feel while getting the results?
Was there anything you didn’t like when they gave you your results? Anything you did like?
What does the HPV result you got mean to you? What does positive or negative mean?
Would you like to receive information on that topic? How would you like to receive that information?
Comparing HPV and Pap testing experiences
Is it worth it to have a cervical cancer screening test? Why?
What would you have liked to be different?
Did they give you the Pap (cervical cytology) and the HPV test?
How often do you get a Pap test? Where do you get it?
Which did you like better, the HPV test or the Pap?
If you could choose between the HPV and Pap test, which would you get? Why?
What didn’t you like about that test?
Do you think there are differences between the tests? What are the differences?
When they did the Pap test, did anything worry you? How did you feel, during the test? And when you
received the results?
And now that they did the HPV test, has anything worried you?
Perceived need for testing
Which women do you think should worry about the Pap test? Which women should have it done?
Which women do you think should worry about the HPV test? Which women should have it done?
Do you think that women’s sex live have anything to do with whether they need cervical cancer detection
tests? With needing the Pap? With needing the HPV test?
Improving the testing experience
What should they do to encourage women to come get the HPV test?
What could they do here in the unit to make it easier for women to get the HPV test?
What could they do here in the unit to make your next HPV test experience better? What could they do to
make it easier for you next time?
Is there anything that I haven’t asked that you would like to share?
doi:10.1371/journal.pone.0153367.t001

Data analysis
Our analytic aim was to assess participants’ perceptions and experiences of HPV and HPV testing in the context of local culture, in relationship to the components of the HBM model
described above. Data analysis was inductive, meaning that it was guided by the specifics of the
data collected rather than a hypothesis based on our theoretical model. The sample size of
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24 participants, with 12 from each site, was sufficient for achieving data saturation in a thematic analysis framework, specifically for identifying themes common to multiple participants
and discerning whether thematic differences existed between the two sites.[31] We identified
emerging themes in interview transcripts related to HPV vulnerability, perceptions of HPV
severity/seriousness, and gender since the latter, while not a component of the HBM model,
was a major theme in participants’ responses. We then developed a code list that reflected
those themes and coded the transcripts using the ATLAS.ti program, collaboratively assessing
the codes and coding for validity and reliability throughout the process. We then organized
data related to the themes we had identified into tables, and identified patterns that emerged
between participants’ experiences (such as spousal infidelity or receipt of written test results)
and their stated understandings of HPV and HPV testing (such as beliefs about HPV symptoms and transmission).[32]

Results
Here, we provide an overview of participant demographics, then present the key themes that
arose in women’s interviews, exemplified with representative quotations. Two main kinds of
results emerged from the data, regarding women’s beliefs about the nature and severity of
HPV, and their perceptions of HPV’s causes and risks (Fig 1. Beliefs, perceptions and behavior
regarding HPV infection among low-income Mexican women. HPV = human papillomavirus,
STI = sexually transmitted infection, HIV = human immunodeficiency virus.).

Fig 1. Beliefs, perceptions and behavior regarding HPV infection among low-income Mexican women. HPV = human papillomavirus,
STI = sexually transmitted infection, HIV = human immunodeficiency virus.
doi:10.1371/journal.pone.0153367.g001
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Table 2. Socio-demographic and clinical characteristics of participants.
Characteristics

Participants
Chilchota (n = 12)

Morelia (n = 12)

30–39

1

6

40–49

9

2

50–59

0

4

60–64

1

0

65

1

0

None

1

0

<6

6

3

6

4

5

7

1

4

Single

0

1

Married/Cohabitating

10

9

Divorced/separated/widowed

2

2

Housewife

4

8

Business employee

5

5

Housekeeper

0

1

Independent vendor

3

0

Yes

11

0

No

1

12

Yes

12

7

No

0

5

0

1

0

1–3

3

6

4–6

6

5

7

2

1

Positive

6

0

Negative

6

12

Age groups (years)

School (years)

Marital status

Occupation type

Indigenous language speaker

Oportunidades program recipient

Births

HPV testing result

doi:10.1371/journal.pone.0153367.t002

Participant demographics
A total of 24 ECDP users, 12 attending each health center, participated in the study. Inclusion
criteria were: being a woman who received HPV testing as primary cervical cancer screening in
the ECDP, receiving HPV test results in the month prior to study recruitment, and having
enough Spanish language fluency to participate in the consent process and interview. All participants invited agreed to participate, except for two who cited lack of time. Participant demographics are described in Table 2. Briefly, they had an average age of 45 years. Most were
married, had children, and had attended 6 or fewer years of school. Almost half identified as
homemakers. Most were beneficiaries of the Oportunidades Program (modified into the Prospera Program after our data collection), a federal cash-transfer program intended to raise
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access to social and health services and increase economic security. [33] Almost half also subscribed to Seguro Popular, a low-cost public health insurance system for Mexican citizens who
lack access to employment-based national health care systems.[34] Of the 24 participants, six
women received a positive HPV test result. Participants had not received health education or
counseling regarding HPV, aside from the clinical explanation that positive HPV test results
would require further follow-up.
Almost half of the participants, all at the Chilchota site, reported that they spoke an indigenous language. The only women who received positive HPV diagnoses were indigenous
women at the Chilchota site. There were no other major differences in the data from the two
sites or from the clinic- versus home-based interviews.

Key themes present in the interviews
In this section we present the key themes that emerged from the interviews, together with representative quotations (Table 3).

Discussion
Confusion about HPV leads to fear
All participants were unsure about the exact nature of HPV. Many hoped that receiving HPV
testing would clarify this issue. Women often assumed that since they were receiving testing for
HPV, it must be a serious disease. All women interviewed associated HPV infection with physical symptoms such as burning, pain, itching or vaginal discharge. Many women believed that
since they were attending a cervical cancer screening program, HPV itself must either be a cancer, be like one, or necessarily cause cancer. Some believed it to be or be similar to HIV/AIDS
(an association likely strengthened by the similar Spanish-language acronyms for HPV (VPH)
and HIV (VIH)). These ideas led women who had not seen the Pap test as especially daunting
to be more frightened by HPV testing, which they associated with potentially severe outcomes.
Women’s perceptions that HPV was very severe related to these beliefs about symptoms, and
to the similarity that women perceived between HPV and HIV.

Fear and confusion regarding HPV testing results
Such misunderstandings of HPV led to great stress for many women undergoing screening.
Women’s knowledge that the disease was sexually transmitted and their fears that it would
inevitably cause distressing symptoms also led participants to believe that many women would
not get tested due to embarrassment. For women who were primary speakers of indigenous
languages, language barriers added to this confusion and augmented their distress. They especially expressed confusion regarding the basic information they were given, for instance understanding “negative” results to mean harmful results, or not understanding the words “positive”
or “negative.” However, as with the woman quoted above who would rather be “hurt” by testing to maintain her long-term health, study participants often said that the emotional discomfort of testing was worth the possibility of arresting terminal illness.
In spite of the perceived benefits of testing, confusing messages from health professionals
regarding notification procedures and test results made the process emotionally painful for
many women. In the ECDP before the introduction of HPV testing, women were notified only
if they required follow-up care for abnormal cytology. With HPV testing, women are notified
of positive HPV test results which might or might not indicate the presence of pre-cancer.
Despite the fact that positive test results are now less closely linked to the presence of pre-cancer, this difference was not communicated and simply receiving results was thus frightening
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Table 3. Key themes.
Theme

Subtheme

Example

Confusion about HPV leads to fear

Lacking HPV knowledge

“I don’t know what this disease is, I’ve just seen on TV that it
affects many women, but I don’t understand how or what it
does” (Chilchota participant).
Wanting doctors “to explain clearly what exactly the human
papillomavirus is, because people don’t really know what the
human papillomavirus is, including me” (Morelia participant).

Assuming HPV is serious and/or is
the same as cervical cancer or like
HIV/AIDS

“What do I have? Is it serious? I was scared and I thought it will
probably be serious, who knows what will happen. . .They gave
me the positive result. . .I think it’s probably serious” (Chilchota
participant).
People with HPV “feel really sick, sometimes they bleed,
sometimes they itch or they feel bad” (Morelia participant).
“I’ve only heard on TV that that people who have [HPV]. . .they get
cancer in their uterus and they die” (Morelia participant).
HPV is “like AIDS or something. . .“causes warts and infections
and all that, it worried me and I said to myself that I would get
[screened] when I saw [the sign publicizing HPV testing]”
(Morelia participant).

Fear and confusion regarding HPV
testing and results

Assumption that HPV testing can
reveal more serious consequences
than Pap testing

The participant usually did not “relate the Pap test with death,” but
said HPV screening made her think “that it might be AIDS or, I
don’t know, I might be really sick” (Morelia participant).

Feeling fear and shame

“I felt bad. . .I felt fear that they’d tell me I had cancer or something
in my uterus. . .they say that’s really dangerous and that’s why I
was scared” (Morelia participant).
“I’m just a little scared. . .because we don’t know what to do with
this [positive test result] or where they’ll send me. . .I want to
know, what is this and where did it come from?” (Chilchota
participant).
“No, I didn’t like it [HPV testing]. . . It made me feel embarrassed”
(Chilchota participant).
“There are people who don’t like to go [to the clinic] to get the
tests. . .it isn’t pleasant but it’s necessary. . . [Women don’t
come] because they’re embarrassed, more than anything
because in those [rural] places there’s lots of people who it
really embarrasses. . .I’m not sure if it’s because of fear or
shame, they don’t want to go . . . it could be because of
ignorance, lots of ignorance.” (Chilchota participant).

Language barriers increase confusion

Wanting doctor to explain, “Am I ok? Or, what’s going on, because
I don’t know how to read. . .or write. . .and I can’t speak well in
Spanish. I want to know what’s going on. . .Am I well or sick?”
(Chilchota participant).

Believing HPV testing will hurt

“I would rather that they hurt me, to take care of my health.”
(Morelia participant).

Confusion about the notiﬁcation
system generates fear

Woman was told simply “. . .that the result isn’t good, that we have
to do it again. . .I don’t understand it” (Chilchota participant).
Woman said she felt fear about the HPV test but not the Pap test,
because “In that one [the Pap] no paperwork came but with this
one [the HPV test] a paper arrived.” (Chilchota participant).

Clearer information given at
colposcopy

Belief that sex a bodily need, but
problematic sexual behavior and
masculinity cause HPV risk

Told at colposcopy “Not to be scared. . .that it wasn’t cancer or
anything serious, but we would have to see how another test
came out that we would do another time. . .Every three years
we do the Pap test” (Chilchota participant).
“There are women who don’t have husbands. . .Sometimes you go
with men because, well, the body needs these things, to have
sex with a man. . .[but this creates risk because] You don’t
know what kind of person they are” (Chilchota participant).
(Continued)
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Table 3. (Continued)
Theme

Subtheme

Example
“I’ve had various partners because I’m separated” but heard that
HPV risk was “related to the partners that one has had”
(Morelia participant).
“I was expecting something bad to come of [my husband’s
inﬁdelity]. . . because I don’t have conﬁdence in my partner. . .
that he’s going to give me an infection or something like that”
(Morelia participant).

Belief that poor hygiene causes HPV
risk

Including men’s poor sexual hygiene

“. . .before there weren’t so many diseases and women didn’t do
these tests, but now the situation has changed. I think there’s
more dirtiness [suciedad] in men, so there are more sicknesses
in women and we have to get treated early” (Morelia
participant).

Including dirty bathrooms

You can get HPV “from public bathrooms, or from a husband who
goes around with other women” (Morelia participant).
“I have a sister who came down with human papillomavirus and it
got me thinking, and that’s why I decided to get tested. Having
a family history. Now I know it’s transmitted by your husband,
but you can also inherit it” (Morelia participant).

Belief that HPV is inheritable

“I’ve only had one partner, my husband, but he’s been gone a
long time. It’s been almost six and a half years since I’ve had
sex.” So, she attributed her HPV positivity to “family history.”
(Chilchota participant).
doi:10.1371/journal.pone.0153367.t003

for participants. This led to experiences like that of a woman in Chilchota, who said that she
never used to worry about cytology screening but became concerned about her HPV test
because of the method of notification of test results. Previously with cytology testing, not
receiving paperwork meant a negative result, but when she underwent HPV testing, “the paper
arrived.” Since under the prior system receiving “paperwork” meant that one was positive for
cervical cancer, participants took positive HPV results to indicate cervical cancer positivity.
Women who received positive HPV test results thus experienced distressing confusion regarding the meanings of those test results and the relationship of HPV to cervical cancer. However,
the two participants who had recently undergone colposcopy felt that they had received clear
explanations about the relationship of HPV positivity to cancer risk. It appears that the explanations provided during colposcopy were more clear and detailed.

Participants’ beliefs about HPV transmission
Women most frequently understood HPV to be transmitted by problematic sexual behavior.
They described desire for sex, for both men and women, as a natural need. However, they
feared their own needs would put them at risk. They understood this risk to be rooted in the
bodies of untrustworthy male partners, viewing men’s negative practices of masculinity, like
promiscuity and infidelity, as actions through which men acquired HPV and would pass it on
to female partners. Participants also understood poor hygiene to be a cause of HPV risk, in
ways that were linked to their understandings of dangerous male sexual behavior. Some
believed that there were more sexually transmitted infections around than in previous eras,
and attributed this development to men’s general dirtiness, which encompassed both lack of
sexual scruples and poor hygiene. Several participants also identified dirty public restrooms as
an additional possible HPV vector. They noted this in concert with the risk posed by men’s
poor sexual hygiene and infidelity; this implied that rumors that HPV can be transmitted by
dirty bathrooms are voiced but seen more as a cover for transmission through male infidelity
than a serious, independent risk factor.
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A few women believed that HPV could be hereditary in addition to sexually transmitted.
They often felt concern and sought screening when female family members received positive
test results. Since women were not informed that HPV can have a very long incubation period,
heritability also seemed like a logical explanation for women who had not had sex for several
years, for example while their husbands were working abroad.

Findings in global and local context
The overall finding that participants understood that HPV was sexually transmitted but were
confused about its symptoms and its relationship to cervical cancer and other STIs mirrors
results from diverse world regions and social classes, indicating that low knowledge regarding
HPV is a global problem.[20,35] Prior studies from similarly diverse populations match the
present finding that women often report low receipt and comprehension of information about
HPV and HPV testing from health personnel.[36,37] Consistent with studies in diverse populations worldwide, [35,38] study participants assumed that HPV was an inevitably serious disease that might be analogous to HIV or necessarily cause cancer. In the present case, both these
misunderstandings about HPV and confusion regarding the testing process itself exacerbated
the fears and negative emotions that women worldwide often experience when they learn
about the sexually transmitted nature of HPV and cervical cancer etiology.[39–42]
We found that study participants shared very similar beliefs about HPV and perceptions of
HPV risk regardless of identifying as mestiza or indigenous, other demographic differences such
as marital status, educational level and number of children, or whether or not they had received a
positive HPV diagnosis. The majority of women participating in the Oportunidades Program
and especially the subset of those women participating in Seguro Popular had more contact with
health professionals, since they had access to more extensive health care services than others.[33]
However, their experiences regarding and ideas about HPV and HPV testing did not differ from
other women’s. Women’s statements that they did not receive clear explanations, and were not
offered explanations in the Indigenous languages which some of them spoke, accord with prior
findings that class and ethnic differences between doctors and Oportunidades patients foster subtle discrimination or hamper health communication.[43,44] The fact that women who had
received colposcopy felt that they had received clearer explanations of HPV reflects inconsistency
in the education provided by health workers performing different aspects of the screening program. Overall, our findings suggest that in this context, the quality of health education about
HPV and communication between health workers and screening program participants must be
improved to enhance low-income Mexican women’s understandings of HPV and improve their
psychosocial experiences of HPV testing. For communication to improve, health professionals
must also have sufficient knowledge about HPV and comfort discussing it to communicate effectively, and lacks in these areas have been documented worldwide.[45–49]
While testing for and diagnosis of sexually transmitted infections can cause emotional pain
and stigma worldwide,[19,41,50,51] local cultural ideas about gender and sexuality shape that
experience. While studies from many regions have found that women often view infidelity as a
key cause of HPV transmission[52–54], participants in the present study incorporated locallyspecific ideas about infidelity as innate to untrustworthy men into their understandings of
HPV risk. In Mexico, popular cultural discussions of masculinity involve heated debate; understandings of male infidelity as natural or inevitable conflict with widespread critiques of
machismo.[24,25] Some women also incorporated locally circulating ideas about unhygienic
bathrooms and hereditary risk into their broader understandings of male “dirtiness” as the primary transmission vector, in ways that helped them understand their own HPV positivity in
the context of sex lives interrupted by men’s work migration.
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The women interviewed here underwent HPV testing despite their confusion and negative
emotions regarding HPV and the testing experience, and their beliefs that others might be too
embarrassed to undergo testing. While this study only included women who had undergone testing and thus did not capture the experiences of women who might have refused it, study participants’ fears about HPV severity facilitated rather than hindered their participation. However,
their testing and diagnosis experiences were characterized by negative emotions related both to
the gendered ideas discussed above, and poor communication by health professionals. This finding suggests that promotion of HPV testing and cervical cancer screening is not enough; culturally- and linguistically-appropriate education about those issues, as well as clearer communication
between health workers and screening participants about these topics, is needed to increase
screening among low-income Mexican women by making it a more positive experience.

Study limitations
This study’s small sample size and focus on women who had participated in screening and
received HPV test results, as well as inclusion only of women who spoke sufficient Spanish,
limits the generalizability of its findings. So does the fact that only indigenous participants in
one of the two research sites received positive HPV diagnoses. However, these qualitative findings provide important information about the perceptions of HPV and its causes that lowincome Mexican women may share. Given that trends in the findings agree with results from
diverse populations worldwide, these results support a call for better HPV-related education
and doctor-patient communication–especially for people receiving HPV testing–worldwide.
They also provide context-specific information that can be useful for improving education and
screening protocols for low-income Mexican women.

Conclusion
Education regarding the causes of HPV, and the fact that high-risk strains might but do not
always inevitably cause cervical cancer in a given individual, is needed worldwide. In Mexico,
EDCP protocols should include clear and comprehensive education about HPV in patients’
native languages, and clear communication and open dialogue regarding HPV testing procedures and the meaning of positive test results in relationship to cervical cancer risk and future
medical appointments. Mexican sexual health care more broadly should also provide space for
patients to discuss fears regarding the relationship of sexually transmitted infections to infidelity, especially in relationship to ongoing cultural debates about masculinity.
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